ES2587136T3 - Lactobacilos con acción antioxidante - Google Patents
Lactobacilos con acción antioxidante Download PDFInfo
- Publication number
- ES2587136T3 ES2587136T3 ES10703681.6T ES10703681T ES2587136T3 ES 2587136 T3 ES2587136 T3 ES 2587136T3 ES 10703681 T ES10703681 T ES 10703681T ES 2587136 T3 ES2587136 T3 ES 2587136T3
- Authority
- ES
- Spain
- Prior art keywords
- casei
- rhamnosus
- termophilus
- lactobacilli
- delbrueckii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Fodder In General (AREA)
Abstract
Cepa de Lactobacillus rhamnosus depositada en la CNMC con el número CNMC I-4271.
Description
Tabla 1: Efecto de las bacterias acidolácticas alimentadas sobre la duración de vida de C. elegans.
- Cepa -Especie
- % de viabilidad
- S2A – S. termophilus
- 95,7
- S1B – S. termophilus
- 98,0
- S2B – S. termophilus
- 94,1
- S1C – S. termophilus
- 94,5
- S1D – S. termophilus
- 98,2
- S1E – S. termophilus
- 100,0
- S1F – S. termophilus
- 95,
- S1G – S. termophilus
- 98,2
- S1H – S. termophilus
- 97,1
- L2A – L. acidophilus
- 91,9
- L5A – L. casei
- 100
- L6A – L. delbrueckii
- 94,1
- L8A – L. johnsoni
- 96,0
- L9A – L. plantarum
- 91,75
- OP50
- 89,5
Esto está según el hallazgo de Ikeda et al. (2007, citado anteriormente).
5 Se ensayó el efecto de 99 cepas de bacterias acidolácticas sobre la supervivencia en estrés oxidativo con H2O2 2, 3 y 5 mM. En la presencia de H2O2 5 mM, la viabilidad en la presencia de E. coli OP50 fue de aproximadamente el 93 % en comparación con la ausencia de estrés. Esto es indicativo de un 93 % de protección frente al estrés oxidativo. La siguiente Tabla 2 muestra el efecto de las bacterias acidolácticas seleccionadas sobre la protección frente al estrés oxidativo, mostrándose el efecto protector ejercido por la E. coli OP50 del control al 100 % como
10 nivel de referencia.
Tabla 2: nivel de protección frente a un estrés oxidativo producido por H2O2 5 mM, conferido por bacterias acidolácticas en comparación con E. coli OP50
- Cepa -Especie
- % de nivel de protección
- E. coli OP50
- 100
- Lactobacilos
- L8F L. plantarum (299v)
- 14,6
- L9F L. rhamnosus (LGG)
- 21,6
- L10F L. rhamnosus
- 9,7
- L1G L. acidophilus
- 102,5
- L3G L. casei
- 7
- L4G – L. casei
- 30
- L6G – L. fermentum
- 23
5
- Cepa -Especie
- % de nivel de protección
- L7G – L. helveticus
- 95
- L8G – L plantarum
- 18
- L9G – L rhamnosus (HN001)
- 81
- L10G – L. rhamnosus
- 77
- L1H – L. amylovorus
- 70
- L4H – L. casei
- 87
- L5H – L. delbrueckii
- 6
- L7H – L. johnsoni
- 3
- L8H – L. plantarum
- 9
- L10H – L. rhamnosus
- 8
- L8B – L. jonhsoni
- 76,8
- L9A – L. plantarum
- 18,7
- L9B – L. plantarum
- 13,3
- L10B – L. rhamnosus
- 5,2
- L11B – L. rhamnosus
- 70,9
- L2C – L. delbrueckii
- 15,7
- L4C – L. brevis
- 12,8
- L6C – L. delbrueckii
- 0,0
- L8C – L. johnsoni
- 59,3
- L10C – L. rhamnosus
- 105
- L11C – L. rhamnosus
- 96,3
- L4D – L. casei
- 7,5
- L6B – L. delbrueckii
- 21,2
- L8B – L. johnsoni
- 82,2
- L5C – L. casei
- 4,1
- L7C-Lactobacillus sp.
- 5,7
- L2D – L. bulgaricus
- 0,0
- L5D – L. casei
- 0,0
- L2E – L. bulgaricus
- 0,0
- L3F – L. casei
- 0,0
- L4F – L. casei
- 85,1
- L6F – L. fermentum
- 0,0
- L7F – L. helveticus
- 11,0
- L11A – L. rhamnosus
- 102
6
- Cepa -Especie
- % de nivel de protección
- L4B – L. casei
- 109
- L3B – L. bulgaricus
- 80,1
- L6A – L. delbrueckii
- 26,3
- L2A – L. acidophilus
- 100
- L2B – L. brevis
- 16,0
- L5A – L. casei
- 9,8
- L7B – L. fermentum
- 0,0
- L5B – L. casei
- 89,6
- L8A – L. johnsoni
- 111
- L8D – L. johnsoni
- 87,1
- L9D – L. reuteri
- 91,6
- L10D – L. rhamnosus
- 94,1
- L11D – L. rhamnosus
- 100
- L3E – L. casei
- 104
- L4E – L. casei
- 59,4
- L5E – L. delbrueckii
- 34,2
- L6E – L. fermentum
- 56,7
- L8E – L. pentosus
- 54,2
- L9E – L. gasseri
- 58,1
- L10E – L. rhamnosus
- 88,6
- L1F – Lactobacillus sp.
- 87,5
- L2F – L. bulgaricus
- 52,2
- L3A – Lactobacillus sp.
- 3
- L1B – L. acidophilus
- 1
- Bifidobacterias
- B1B – B. animalis
- 35,8
- B1C – B. animalis
- 26,2
- B1D – B. animalis
- 7,4
- B1E – B. animalis
- 0,0
- B1G – B. bifidum
- 9,0
- B2G – B. longum
- 5,9
- Estreptococos
7
Claims (1)
-
imagen1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2010/000194 WO2011083354A1 (en) | 2010-01-08 | 2010-01-08 | Lactobacilli with anti-oxidant action |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2587136T3 true ES2587136T3 (es) | 2016-10-20 |
Family
ID=42105947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10703681.6T Active ES2587136T3 (es) | 2010-01-08 | 2010-01-08 | Lactobacilos con acción antioxidante |
Country Status (8)
Country | Link |
---|---|
US (1) | US9056123B2 (es) |
EP (1) | EP2521769B1 (es) |
CN (1) | CN102858948B (es) |
BR (1) | BR112012016894A2 (es) |
EA (1) | EA024911B1 (es) |
ES (1) | ES2587136T3 (es) |
PL (1) | PL2521769T3 (es) |
WO (1) | WO2011083354A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102618456B (zh) * | 2012-02-28 | 2013-08-21 | 江南大学 | 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途 |
EP2863929B1 (en) | 2012-06-22 | 2016-07-20 | Nestec S.A. | Probiotic and polyphenol against neurodegeneration |
JP2016507216A (ja) * | 2012-11-12 | 2016-03-10 | コンパニ・ジェルベ・ダノンCompagnie Gervais Danone | 体脂肪の蓄積を低減させるためのラクトバチルスラムノサス株 |
EP2917335B1 (en) * | 2012-11-12 | 2018-04-04 | Compagnie Gervais Danone | Use of lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance |
US20160279180A1 (en) * | 2013-08-23 | 2016-09-29 | Consejo Superior de Investigaciones Científicas ( CSIC) | Probiotic Strain of Lactobacillus Reuteri Exhibiting Anti-Helicobacter Activity, a Probiotic or Biotherapeutic Product Comprising Said Strain, and the Use Thereof |
WO2015159125A1 (en) * | 2014-04-15 | 2015-10-22 | Compagnie Gervais Danone | Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after antibiotic dysbiosis |
US9468659B2 (en) * | 2014-11-06 | 2016-10-18 | NWO Stem Cure, LLC | Nutraceutical supplement with Lactobacillus rhamnosus |
RU2617946C1 (ru) * | 2015-11-24 | 2017-04-28 | Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" | Штаммы Lactobacillus brevis и Lactobacillus rhamnosus с установленной последовательностью генома, синтезирующие глутатион и комплекс внутриклеточных антиоксидантов |
RU2705250C2 (ru) * | 2018-02-05 | 2019-11-06 | Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" | Штамм Lactobacillus fermentum U-21, продуцирующий комплекс биологически активных веществ, осуществляющих нейтрализацию супероксид-аниона, индуцируемого химическими агентами |
CN108410761B (zh) * | 2018-03-06 | 2020-03-20 | 山东凤凰生物有限公司 | 一株具有降亚硝酸盐、抗氧化的鼠李糖乳杆菌及筛选分离方法 |
US20220241357A1 (en) * | 2019-06-14 | 2022-08-04 | Compagnie Gervais Danone | Composition for amelioration of anxiety and/or stress |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0649603B1 (en) | 1993-05-11 | 2000-10-25 | Otsuka Pharmaceutical Co., Ltd. | Antioxidant food, antioxidant preparation and antioxidization method |
WO1996020607A1 (fr) | 1995-01-02 | 1996-07-11 | Compagnie Gervais Danone | Ferment lactique, et son utilisation pour la preparation de produits anti-diarrheiques |
SE510753C2 (sv) * | 1997-08-05 | 1999-06-21 | Probi Ab | Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod |
PL347029A1 (en) | 1998-10-01 | 2002-03-11 | Probi Ab | Reduction of oxidative stress factors |
SE523771C2 (sv) * | 1999-05-21 | 2004-05-18 | Probi Ab | Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller |
FR2809312B1 (fr) * | 2000-05-25 | 2002-07-12 | Gervais Danone Sa | Utilisation de l. casei dans des compositions immunostimulantes |
EE04580B1 (et) | 2001-06-29 | 2006-02-15 | Tartu �likool | Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum |
GB0319503D0 (en) * | 2003-08-19 | 2003-09-17 | Danisco | Process |
FR2876029B1 (fr) * | 2004-10-04 | 2008-11-14 | Oreal | Composition cosmetique et/ou dermatologique pour peaux sensibles. |
US20100310713A1 (en) * | 2007-09-21 | 2010-12-09 | Kerry Group Services International Limited | Probiotic composition |
FR2928935B1 (fr) * | 2008-03-19 | 2011-05-20 | Gervais Danone Sa | Souche de lactobacillus rhamnosus. |
-
2010
- 2010-01-08 BR BR112012016894A patent/BR112012016894A2/pt not_active Application Discontinuation
- 2010-01-08 EP EP10703681.6A patent/EP2521769B1/en active Active
- 2010-01-08 EA EA201290623A patent/EA024911B1/ru not_active IP Right Cessation
- 2010-01-08 WO PCT/IB2010/000194 patent/WO2011083354A1/en active Application Filing
- 2010-01-08 CN CN201080060947.1A patent/CN102858948B/zh active Active
- 2010-01-08 US US13/520,456 patent/US9056123B2/en active Active
- 2010-01-08 PL PL10703681T patent/PL2521769T3/pl unknown
- 2010-01-08 ES ES10703681.6T patent/ES2587136T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
US20130171117A1 (en) | 2013-07-04 |
US9056123B2 (en) | 2015-06-16 |
EP2521769A1 (en) | 2012-11-14 |
BR112012016894A2 (pt) | 2015-09-15 |
EA024911B1 (ru) | 2016-11-30 |
CN102858948A (zh) | 2013-01-02 |
PL2521769T3 (pl) | 2017-01-31 |
CN102858948B (zh) | 2015-11-25 |
WO2011083354A1 (en) | 2011-07-14 |
EP2521769B1 (en) | 2016-05-18 |
EA201290623A1 (ru) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2587136T3 (es) | Lactobacilos con acción antioxidante | |
ES2561253T3 (es) | Bacterias probióticas que tienen actividad antioxidante y uso de las mismas | |
ES2616334T3 (es) | Probióticos, IgA secretora e infección | |
BR112018069284A2 (pt) | composição probiótica e seu uso no tratamento e/ou prevenção da psoríase | |
PE20190417A1 (es) | Uso de probioticos en el tratamiento y/o la prevencion de la dermatitis atopica | |
AR094025A1 (es) | Utilizacion de bifidobacterium animalis para el tratamiento o la prevencion de la ganancia de peso corporal y de la resistencia a la insulina | |
NZ712959A (en) | Probiotic strains for use in treatment or prevention of osteoporosis | |
CL2011001939A1 (es) | Uso de lactobacillus helveticus cncm i-4095 para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales, particularmente para tratar la obesidad y trastornos metabólicos; y microorganismo de la cepa de lactobacillus helveticus cncm i-4095. | |
PH12018550110A1 (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
CL2011001937A1 (es) | Uso de la cepa de lactobacillus rhamnosus cncm i-4096 para apoyar la pérdida de peso y/o mantenimiento del peso en humanos y/o animales, específicamente para el tratamiento de la obesidad. | |
WO2019004684A3 (ko) | 나노화된 김치 유산균을 함유하는 피부 주름 개선 또는 피부 보습용 화장료 조성물 | |
DK3554517T3 (da) | Probiotisk sammensætning omfattende lactobacillus rhamnosus og lactobacillus paracasei stammer | |
MX2016001764A (es) | Cepa de lactobacillus pentosus como probiotico. | |
HRPK20130487B3 (hr) | Formulacija probiotika s apigeninom i ekstraktom paprene metvice | |
ES2543738T3 (es) | Método para seleccionar bacterias con acción antioxidante | |
EP3027734B8 (en) | Isolated microorganism strain lactobacillus plantarum tak 59 ncimb42150 and its use | |
CO2017007338A2 (es) | Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina | |
MX2016015172A (es) | Nueva cepa de lactobacilus casei con capacidad para degradar el peptido inmunotoxico del gluten. | |
RS57471B1 (sr) | Nova probiotička starter kultura za humanu i animalnu primenu | |
WO2014096083A3 (fr) | Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine | |
Rubel et al. | USE OF PROBITIC MICROORGANISMS IN COSMETIC MEDICINAL PRODUCTS | |
RU2012108361A (ru) | Штамм лактозосбраживающих бактерий enterococcus hirae вкпм в-9069 - продуцент молочной кислоты и пробиотиков | |
RS54225B1 (en) | Indigenous LACTOBACILLUS strains and their use as probiotics | |
PL401554A1 (pl) | Szczep bakterii mlekowych Lactobacillus plantarum | |
RU2008133794A (ru) | Штамм lactobacillus fermentum z для использования в лечебно-профилактических средствах |